Johnson & Johnson on Tuesday projected that its Covid vaccine would generate $3 billion to $3.5 billion in sales in 2022, after posting a mixed fourth-quarter report that slightly beat on earnings estimates but missed on revenue.

Imagine getting a positive result on a genetic test. The doctor tells you that you have a “pathogenic genetic variant,” or a DNA sequence that is known to raise the chances for getting a disease like breast cancer or diabetes.

Gene editing company Metagenomi said on Tuesday that it has raised $175 million in a Series B financing round, bringing the total funding for the Emeryville, California-based startup to $300 million.

Shenzhen, China, January 24, 2022: Medcaptain Medical Technology and Penlon, a world-renowned medical device manufacturer, formally entered into an acquisition.

Recently, Novogene released the finance forecast that the net profit attributable to owners of the parent company in 2021 was 190 million to 228 million yuan, a year-on-year increase of 419.99% to 523.99%.

Illumina said on Monday that it is collaborating with National Cancer Center Japan on a study of nasopharyngeal carcinoma.

While the Omicron variant continues to infect people around the world, researchers at the University of Missouri have identified the highly prevalent, specific mutations that are causing the Omicron variant’s high rate of infection.

Pancreatic cancer is a rare, yet elusive and deadly cancer, with a five-year survival rate of about 10%. If the cancer has metastasized, that rate lowers to 3%. And treatment options are extremely limited.

Kent, UK-based point-of-care test developer Psyros Diagnostics on Thursday announced it is being acquired by Prolight Diagnostics, based in Lund, Sweden, for SEK 65 million ($7.1 million).

On January 19, Hangzhou Bioer Technology Co., Ltd. signed a strategic cooperation agreement with Dell.

Research from the School of Medicine suggests how a newly developed gene therapy can treat Dravet syndrome, a severe form of epilepsy, and potentially prolong survival for people with the condition.

Ginkgo Bioworks said on Wednesday that it has acquired Project Beacon COVID-19, a Boston-based coronavirus testing organization.

Cancer diagnostics firm Oncocyte said Tuesday that it has entered into a collaboration and comarketing agreement with Thermo Fisher Scientific for two cancer in vitro diagnostic tests.

Molecular diagnostic company Canary Global announced on Tuesday that it received CE marking last week for its DigiGene COVID-19 Rapid Molecular Test Kit.

Today, the Top Employers Institute released the Top Employers China 2022 list of certified organizations. Danaher, Roche, Abbott, Ortho, Biomeier, BD and other companies have won the "Top Employers China 2022" certification.